2020
DOI: 10.1002/smll.202002931
|View full text |Cite
|
Sign up to set email alerts
|

Crosslinking Strategies for 3D Bioprinting of Polymeric Hydrogels

Abstract: Three‐dimensional (3D) bioprinting has recently advanced as an important tool to produce viable constructs that can be used for regenerative purposes or as tissue models. To develop biomimetic and sustainable 3D constructs, several important processing aspects need to be considered, among which crosslinking is most important for achieving desirable biomechanical stability of printed structures, which is reflected in subsequent behavior and use of these constructs. In this work, crosslinking methods used in 3D … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
243
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 216 publications
(294 citation statements)
references
References 277 publications
(175 reference statements)
1
243
0
Order By: Relevance
“…Hence, this system acts as a pre‐crosslinking strategy and enhances cell viability of the overall constructs. [ 241 ] Li et al. reported cell viability of >96% (mouse myoblasts cells C2C12) up to day 2, utilizing this strategy with extrusion‐based printing.…”
Section: Crosslinking Of Bioinkmentioning
confidence: 99%
See 3 more Smart Citations
“…Hence, this system acts as a pre‐crosslinking strategy and enhances cell viability of the overall constructs. [ 241 ] Li et al. reported cell viability of >96% (mouse myoblasts cells C2C12) up to day 2, utilizing this strategy with extrusion‐based printing.…”
Section: Crosslinking Of Bioinkmentioning
confidence: 99%
“…However, this crosslinking method has a short shelf life, and oxidation of disulfide bonds causes poor thermal stability. [ 241 ] Some notable crosslinking examples include thiol‐norbornene (mouse fibroblast L929 with 81 ± 4.4% viability and chondrogenic cell line (ATDC 5) with 93 ± 2.8% viability at day 1); [ 251 ] thiol‐allyl (human and equine MSC with cell viability and differentiability upto 21 days), [ 252 ] (human bone marrow derived MSC with cell viability of 78.9 ± 13.5% at day 1) etc.…”
Section: Crosslinking Of Bioinkmentioning
confidence: 99%
See 2 more Smart Citations
“…Furthermore, bioprinting, as a type of additive manufacturing, is amenable to scaled up tissue fabrication and manufacturing, an important consideration as clinical use of fabricated tissues increases (Wu et al, 2017;Skylar-Scott et al, 2019;Castilho et al, 2020). The development of materials compatible with cells and other biologics, so called "bioinks" has also exploded involving a variety of artificial and native material types (Chimene et al, 2016;Chan et al, 2020;Cui et al, 2020), material sourcing (Abaci and Guvendiren, 2020), curing features (GhavamiNejad et al, 2020), and utilities (Whitford and Hoying, 2016;Unagolla and Jayasuriya, 2020). While the practical aspects and applications involving bioprinting are actively explored (as indicated by the recent burst of informative reviews on bioprinting and bioinks), the integration of biological responses and dynamics in bioprinted systems are less addressed.…”
Section: Introductionmentioning
confidence: 99%